EMA Advocates Suspension Of All Ranitidine Drugs In EU
Executive Summary
Concerns over the presence of a probable human carcinogen will likely see marketing of all ranitidine-containing drugs suspended across the European Union.
You may also be interested in...
Europe Spells Out Conditions For Return Of Ranitidine
EMA has set out four conditions which marketing authorization holders must meet before the suspension of ranitidine across Europe can be lifted.
EMA Stands By Suspension Of Ranitidine
Suspension of heartburn remedy ranitidine looming in the EU as the European Medicines Agency stands by its original decision.
EMA Stands By Suspension Of Ranitidine In EU After Re-Examination
Suspension of heartburn remedy ranitidine looming in the EU as the European Medicines Agency stands by its original decision.